NorthCrest Asset Manangement’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
1,656
+161
+11% +$31.6K 0.01% 687
2026
Q1
$296K Sell
1,495
-500
-25% -$97.1K 0.01% 621
2025
Q4
$346K Buy
1,995
+25
+1% +$4.55K 0.01% 647
2025
Q3
$358K Buy
1,970
+24
+1% +$4.26K 0.01% 575
2025
Q2
$344K Sell
1,946
-279
-13% -$48.5K 0.01% 486
2025
Q1
$376K Buy
2,225
+115
+5% +$18.9K 0.01% 469
2024
Q4
$318K Sell
2,110
-56
-3% -$8.71K 0.01% 478
2024
Q3
$336K Sell
2,166
-47
-2% -$7.02K 0.01% 464
2024
Q2
$303K Buy
2,213
+13
+0.6% +$1.78K 0.01% 452
2024
Q1
$293K Sell
2,200
-248
-10% -$32.2K 0.01% 449
2023
Q4
$338K Buy
2,448
+35
+1% +$4.6K 0.01% 435
2023
Q3
$294K Sell
2,413
-75
-3% -$9.99K 0.01% 443
2023
Q2
$350K Sell
2,488
-141
-5% -$19.4K 0.01% 422
2023
Q1
$372K Buy
2,629
+329
+14% +$47.1K 0.02% 417
2022
Q4
$360K Sell
2,300
-647
-22% -$93K 0.02% 340
2022
Q3
$362K Sell
2,947
-13,066
-82% -$1.72M 0.02% 343
2022
Q2
$2.13M Buy
16,013
+13,410
+515% +$1.83M 0.11% 152
2022
Q1
$357K Sell
2,603
-14,720
-85% -$2.05M 0.02% 343
2021
Q4
$3M Buy
+17,323
New +$2.64M 0.16% 121

Other funds holding DGX

NorthCrest Asset Manangement's DGX Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $31.6K and bringing the position to 1,656 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #687.

NorthCrest Asset Manangement first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $3M in Q4 2021. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • NorthCrest Asset Manangement held 1,656 shares of Quest Diagnostics worth $345K as of Q2 2026.
  • NorthCrest Asset Manangement bought 161 Quest Diagnostics shares in Q2 2026, an estimated $31.6K.
  • Quest Diagnostics made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #687 holding.
  • NorthCrest Asset Manangement first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Quest Diagnostics position peaked at $3M in Q4 2021.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.